According to Apollo Medical Holdings's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 36.7748. At the end of 2022 the company had a P/E ratio of 27.1.
Year | P/E ratio | Change |
---|---|---|
2022 | 27.1 | -37.93% |
2021 | 43.7 | 151.37% |
2020 | 17.4 | -61.81% |
2019 | 45.6 | -24.88% |
2018 | 60.7 | |
2016 | -4.93 | -7.76% |
2015 | -5.34 | |
2013 | -5.54 | 186.48% |
2012 | -1.93 | -74.22% |
2011 | -7.50 | -50% |
2010 | -15.0 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
National Healthcare
NHC | 48.0 | 30.50% | ๐บ๐ธ USA |
Acadia Healthcare
ACHC | 22.3 | -39.40% | ๐บ๐ธ USA |
Capital Senior Living
CSU | N/A | N/A | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.